Total Payments
$9,018
2024 Payments
$972.71
Companies
66
Transactions
487
Medicare Patients
13,672
Medicare Billing
$3.9M
Payment Breakdown by Category
Food & Beverage$9,004 (99.8%)
Education$13.84 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,004 | 480 | 99.8% |
| Education | $13.84 | 7 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $1,259 | 41 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $819.68 | 88 | $0 (2023) |
| Vertos Medical, Inc. | $459.22 | 13 | $0 (2024) |
| BIOTRONIK NRO, Inc. | $433.56 | 8 | $0 (2024) |
| Sentynl Therapeutics, Inc. | $400.24 | 26 | $0 (2020) |
| Collegium Pharmaceutical, Inc. | $399.56 | 31 | $0 (2022) |
| Medtronic, Inc. | $364.00 | 9 | $0 (2024) |
| Abbott Laboratories | $360.94 | 10 | $0 (2024) |
| Egalet US Inc | $292.79 | 35 | $0 (2018) |
| Nevro Corp. | $280.50 | 10 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $972.71 | 23 | BIOTRONIK NRO, Inc. ($337.24) |
| 2023 | $1,668 | 71 | Boston Scientific Corporation ($495.65) |
| 2022 | $1,349 | 73 | BOSTON SCIENTIFIC CORPORATION ($322.72) |
| 2021 | $1,139 | 65 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($203.05) |
| 2020 | $609.14 | 31 | Abbott Laboratories ($86.58) |
| 2019 | $616.53 | 32 | Sentynl Therapeutics, Inc. ($118.62) |
| 2018 | $994.56 | 55 | Sentynl Therapeutics, Inc. ($137.44) |
| 2017 | $1,669 | 137 | Egalet US Inc ($258.14) |
All Payment Transactions
487 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $29.97 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 12/10/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Food and Beverage | In-kind items and services | $33.75 | General |
| Category: Not Applicable | ||||||
| 11/11/2024 | Curonix LLC | PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: PAIN MANAGEMENT | ||||||
| 10/08/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $32.17 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 09/27/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Food and Beverage | In-kind items and services | $129.45 | General |
| Category: Not Applicable | ||||||
| 09/26/2024 | Curonix LLC | PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) | Food and Beverage | In-kind items and services | $96.57 | General |
| Category: PAIN MANAGEMENT | ||||||
| 09/20/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: Neuromodulation | ||||||
| 09/10/2024 | Vertos Medical, Inc. | mild Device Kit (Device) | Food and Beverage | In-kind items and services | $55.99 | General |
| Category: Orthopedic | ||||||
| 08/19/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Food and Beverage | In-kind items and services | $132.37 | General |
| Category: Not Applicable | ||||||
| 08/14/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $61.24 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 08/06/2024 | PAINTEQ LLC | PAINTEQ (Device) | Food and Beverage | In-kind items and services | $25.68 | General |
| Category: PAIN MANAGEMENT | ||||||
| 07/18/2024 | Vertos Medical, Inc. | mild Device Kit (Device) | Food and Beverage | In-kind items and services | $25.56 | General |
| Category: Orthopedic | ||||||
| 07/18/2024 | Electronic Waveform Lab, Inc. | — | Food and Beverage | Cash or cash equivalent | $16.09 | General |
| 07/17/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: Not Applicable | ||||||
| 06/28/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Neuromodulation | ||||||
| 06/04/2024 | Vertos Medical, Inc. | mild Device Kit (Device) | Food and Beverage | In-kind items and services | $56.81 | General |
| Category: Orthopedic | ||||||
| 05/24/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $15.66 | General |
| 05/13/2024 | Vertos Medical, Inc. | mild Device Kit (Device) | Food and Beverage | In-kind items and services | $59.46 | General |
| Category: Orthopedic | ||||||
| 05/08/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Food and Beverage | In-kind items and services | $25.49 | General |
| Category: Not Applicable | ||||||
| 04/27/2024 | PAINTEQ LLC | PAINTEQ (Device) | Food and Beverage | In-kind items and services | $24.35 | General |
| Category: PAIN MANAGEMENT | ||||||
| 04/04/2024 | Vertos Medical, Inc. | mild Device Kit (Device) | Food and Beverage | In-kind items and services | $50.10 | General |
| Category: Orthopedic | ||||||
| 03/06/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 02/26/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 12/26/2023 | Vertos Medical, Inc. | mild Device Kit (Device) | Food and Beverage | In-kind items and services | $39.39 | General |
| Category: Orthopedic | ||||||
| 12/18/2023 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $20.71 | General |
| Category: Spinal Cord Neurostimulation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 1,508 | 2,274 | $1.5M | $299,249 |
| 2022 | 28 | 2,893 | 15,206 | $3.3M | $766,495 |
| 2021 | 33 | 4,295 | 15,268 | $4.3M | $1.5M |
| 2020 | 33 | 4,976 | 25,826 | $4.6M | $1.3M |
Total Patients
13,672
Total Services
58,574
Medicare Billing
$3.9M
Procedure Codes
123
All Medicare Procedures & Services
123 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 0275T | Removal of bone from lower spine for decompression of nerve tissue using imaging guidance, accessed through the skin | Facility | 2023 | 60 | 90 | $315,000 | $72,409 | 23.0% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2023 | 127 | 253 | $144,150 | $26,959 | 18.7% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 112 | 119 | $170,170 | $26,757 | 15.7% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2023 | 109 | 206 | $125,970 | $23,739 | 18.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 146 | 146 | $84,680 | $19,092 | 22.5% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2023 | 126 | 250 | $83,280 | $15,076 | 18.1% |
| 63650 | Insertion of spinal neurostimulator electrode array through skin | Facility | 2023 | 21 | 54 | $77,760 | $13,846 | 17.8% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Facility | 2023 | 49 | 96 | $61,790 | $11,403 | 18.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 111 | 149 | $47,680 | $10,980 | 23.0% |
| 64633 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 44 | 48 | $65,520 | $10,559 | 16.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 79 | 101 | $45,450 | $9,576 | 21.1% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 47 | 49 | $29,400 | $9,544 | 32.5% |
| 64625 | Destruction of nerves supplying joint between spine and pelvis using imaging guidance | Facility | 2023 | 34 | 38 | $40,200 | $7,873 | 19.6% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 106 | 112 | $45,900 | $7,452 | 16.2% |
| 64491 | Injection of upper or middle spine facet joint using imaging guidance, second level | Facility | 2023 | 49 | 94 | $34,930 | $6,352 | 18.2% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2023 | 35 | 63 | $21,420 | $4,940 | 23.1% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Facility | 2023 | 26 | 48 | $17,760 | $3,996 | 22.5% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Facility | 2023 | 40 | 46 | $19,720 | $3,862 | 19.6% |
| 64634 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 44 | 48 | $25,350 | $3,614 | 14.3% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Facility | 2023 | 43 | 77 | $13,860 | $3,335 | 24.1% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 47 | 49 | $9,310 | $2,984 | 32.1% |
| 63685 | Insertion of spinal neurostimulator generator or receiver | Facility | 2023 | 15 | 15 | $19,200 | $2,831 | 14.7% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 25 | 35 | $10,120 | $2,063 | 20.4% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 13 | 88 | $880.00 | $8.16 | 0.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 1,059 | 5,217 | $1.9M | $477,107 | 25.2% |
About Dr. Varada Nargund, DO
Dr. Varada Nargund, DO is a Interventional Pain Medicine healthcare provider based in Glen Burnie, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1417032277.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Varada Nargund, DO has received a total of $9,018 in payments from pharmaceutical and medical device companies, with $972.71 received in 2024. These payments were reported across 487 transactions from 66 companies. The most common payment nature is "Food and Beverage" ($9,004).
As a Medicare-enrolled provider, Nargund has provided services to 13,672 Medicare beneficiaries, totaling 58,574 services with total Medicare billing of $3.9M. Data is available for 4 years (2020–2023), covering 123 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Pain Medicine
- Location Glen Burnie, MD
- Active Since 10/27/2006
- Last Updated 06/18/2021
- Taxonomy Code 208VP0014X
- Entity Type Individual
- NPI Number 1417032277
Products in Payments
- RELISTOR (Drug) $703.95
- WaveWriter Alpha Prime 16 (Device) $668.90
- mild Device Kit (Device) $459.22
- Prospera (Device) $337.24
- Levorphanol (Drug) $267.49
- INTELLIS ADAPTIVESTIM (Device) $259.90
- Zilretta (Drug) $249.17
- Evzio (Drug) $224.67
- XTAMPZA (Drug) $223.73
- SPECTRA WAVEWRITER (Device) $217.24
- iFuse Implant (Device) $216.00
- Infinion 16 (Device) $206.40
- Omnia (Device) $182.50
- SPRIX (Drug) $174.43
- HYSINGLA ER (Drug) $147.30
- PROCLAIM (Device) $137.34
- Xtampza ER (Drug) $134.44
- RELISTOR ORAL (Drug) $131.84
- Morphabond ER (Drug) $130.19
- MOVANTIK (Drug) $128.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.